Published in Magn Reson Med on September 01, 2004
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med (2014) 3.27
Quantitative evaluation of oxygenation in venous vessels using T2-Relaxation-Under-Spin-Tagging MRI. Magn Reson Med (2008) 2.42
Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol (2014) 2.12
Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med (2009) 1.97
Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magn Reson Med (2010) 1.91
Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care (2007) 1.77
Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging (2011) 1.73
Alterations in cerebral metabolic rate and blood supply across the adult lifespan. Cereb Cortex (2010) 1.63
Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition. Hum Brain Mapp (2011) 1.45
Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation. Magn Reson Med (2011) 1.40
Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI. J Cereb Blood Flow Metab (2012) 1.36
QUantitative Imaging of eXtraction of oxygen and TIssue consumption (QUIXOTIC) using venular-targeted velocity-selective spin labeling. Magn Reson Med (2011) 1.35
Phase-based regional oxygen metabolism (PROM) using MRI. Magn Reson Med (2011) 1.30
Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med (2011) 1.29
Baseline blood oxygenation modulates response amplitude: Physiologic basis for intersubject variations in functional MRI signals. Magn Reson Med (2008) 1.27
Evaluation of MRI models in the measurement of CMRO2 and its relationship with CBF. Magn Reson Med (2008) 1.27
Assessment of thalamic perfusion in patients with mild traumatic brain injury by true FISP arterial spin labelling MR imaging at 3T. Brain Inj (2009) 1.27
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology (2009) 1.26
Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T. Neuroimage (2010) 1.23
In vivo venous blood T1 measurement using inversion recovery true-FISP in children and adults. Magn Reson Med (2010) 1.15
CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging (2012) 1.15
Caffeine reduces the activation extent and contrast-to-noise ratio of the functional cerebral blood flow response but not the BOLD response. Neuroimage (2008) 1.15
Arterial spin-labeled MR perfusion imaging: clinical applications. Magn Reson Imaging Clin N Am (2009) 1.13
MRI of blood flow of the human retina. Magn Reson Med (2011) 1.12
Absolute arterial cerebral blood volume quantification using inflow vascular-space-occupancy with dynamic subtraction magnetic resonance imaging. J Cereb Blood Flow Metab (2010) 1.11
Longitudinal reproducibility and accuracy of pseudo-continuous arterial spin-labeled perfusion MR imaging in typically developing children. Radiology (2012) 1.11
Hematocrit and oxygenation dependence of blood (1)H(2)O T(1) at 7 Tesla. Magn Reson Med (2012) 1.10
Anatomical differences and network characteristics underlying smoking cue reactivity. Neuroimage (2010) 1.08
Quantitative basal CBF and CBF fMRI of rhesus monkeys using three-coil continuous arterial spin labeling. Neuroimage (2006) 1.07
Life-long aerobic exercise preserved baseline cerebral blood flow but reduced vascular reactivity to CO2. J Magn Reson Imaging (2013) 1.07
Baseline CBF, and BOLD, CBF, and CMRO2 fMRI of visual and vibrotactile stimulations in baboons. J Cereb Blood Flow Metab (2010) 1.05
Determination of spin compartment in arterial spin labeling MRI. Magn Reson Med (2011) 1.05
Inflow-based vascular-space-occupancy (iVASO) MRI. Magn Reson Med (2011) 1.04
On improving the speed and reliability of T2-relaxation-under-spin-tagging (TRUST) MRI. Magn Reson Med (2011) 1.04
Physiological origin for the BOLD poststimulus undershoot in human brain: vascular compliance versus oxygen metabolism. J Cereb Blood Flow Metab (2011) 1.04
Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease. Eur Radiol (2009) 1.03
An arterial spin labeling investigation of cerebral blood flow deficits in chronic stroke survivors. Neuroimage (2010) 1.02
Combined measurement of perfusion, venous oxygen saturation, and skeletal muscle T2* during reactive hyperemia in the leg. J Cardiovasc Magn Reson (2013) 1.02
Comparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imaging. J Cereb Blood Flow Metab (2013) 1.00
Blood longitudinal (T1) and transverse (T2) relaxation time constants at 11.7 Tesla. MAGMA (2011) 1.00
Bolus arrival time and cerebral blood flow responses to hypercarbia. J Cereb Blood Flow Metab (2014) 1.00
Quantification of myocardial perfusion using CMR with a radial data acquisition: comparison with a dual-bolus method. J Cardiovasc Magn Reson (2010) 0.99
Longitudinal diffusion tensor imaging and perfusion MRI investigation in a macaque model of neuro-AIDS: a preliminary study. Neuroimage (2011) 0.98
Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med (2012) 0.98
Modified pulsed continuous arterial spin labeling for labeling of a single artery. Magn Reson Med (2010) 0.97
Applications and limitations of whole-brain MAGIC VASO functional imaging. Magn Reson Med (2007) 0.97
Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magn Reson Med (2008) 0.97
Measurement of absolute arterial cerebral blood volume in human brain without using a contrast agent. NMR Biomed (2011) 0.96
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage (2012) 0.96
Image-based calculation of perfusion and oxyhemoglobin saturation in skeletal muscle during submaximal isometric contractions. Magn Reson Med (2010) 0.96
The BOLD post-stimulus undershoot, one of the most debated issues in fMRI. Neuroimage (2012) 0.95
Fast measurement of blood T1 in the human jugular vein at 3 Tesla. Magn Reson Med (2010) 0.95
A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct (2013) 0.94
Measurement of T1 and T2 in the cervical spinal cord at 3 tesla. Magn Reson Med (2008) 0.93
Venous oxygenation mapping using velocity-selective excitation and arterial nulling. Magn Reson Med (2012) 0.93
Blood flow MRI of the human retina/choroid during rest and isometric exercise. Invest Ophthalmol Vis Sci (2012) 0.92
In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging (2010) 0.91
Effect of inflow of fresh blood on vascular-space-occupancy (VASO) contrast. Magn Reson Med (2009) 0.91
Decreased retinal-choroidal blood flow in retinitis pigmentosa as measured by MRI. Doc Ophthalmol (2013) 0.90
Rapid 3D dynamic arterial spin labeling with a sparse model-based image reconstruction. Neuroimage (2015) 0.90
Radiation damping in modern NMR experiments: progress and challenges. Prog Nucl Magn Reson Spectrosc (2012) 0.90
Absolute cerebral blood flow quantification with pulsed arterial spin labeling during hyperoxia corrected with the simultaneous measurement of the longitudinal relaxation time of arterial blood. Magn Reson Med (2011) 0.90
Noncontrast dynamic 3D intracranial MR angiography using pseudo-continuous arterial spin labeling (PCASL) and accelerated 3D radial acquisition. J Magn Reson Imaging (2013) 0.90
Simultaneous multi-slice Turbo-FLASH imaging with CAIPIRINHA for whole brain distortion-free pseudo-continuous arterial spin labeling at 3 and 7 T. Neuroimage (2015) 0.89
The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography (2016) 0.89
Visualization of altered neurovascular coupling in chronic stroke patients using multimodal functional MRI. J Cereb Blood Flow Metab (2012) 0.89
Current trends and challenges in MRI acquisitions to investigate brain function. Int J Psychophysiol (2009) 0.89
Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease. Magn Reson Med (2014) 0.88
Direct saturation MRI: theory and application to imaging brain iron. Magn Reson Med (2009) 0.88
Pseudocontinuous arterial spin labeling with optimized tagging efficiency. Magn Reson Med (2012) 0.88
Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity. Neurobiol Aging (2009) 0.88
Physiologic underpinnings of negative BOLD cerebrovascular reactivity in brain ventricles. Neuroimage (2013) 0.88
High-resolution myocardial perfusion imaging at 3 T: comparison to 1.5 T in healthy volunteers. Eur Radiol (2007) 0.87
Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses. Neuroimage (2012) 0.87
Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography. NMR Biomed (2011) 0.87
Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease. Neuroimage Clin (2014) 0.86
Whole-brain three-dimensional T2-weighted BOLD functional magnetic resonance imaging at 7 Tesla. Magn Reson Med (2013) 0.86
Measurement of T1 of human arterial and venous blood at 7T. Magn Reson Imaging (2012) 0.86
Magnetization transfer enhanced vascular-space-occupancy (MT-VASO) functional MRI. Magn Reson Med (2009) 0.86
Regional quantification of cerebral venous oxygenation from MRI susceptibility during hypercapnia. Neuroimage (2014) 0.85
Quantitative analysis of arterial spin labeling FMRI data using a general linear model. Magn Reson Imaging (2010) 0.85
Dependence of blood T(2) on oxygenation at 7 T: in vitro calibration and in vivo application. Magn Reson Med (2013) 0.84
Impact of neonate haematocrit variability on the longitudinal relaxation time of blood: Implications for arterial spin labelling MRI. Neuroimage Clin (2014) 0.84
Absence of a significant extravascular contribution to the skeletal muscle BOLD effect at 3 T. Magn Reson Med (2010) 0.84
T1 and T2 values of human neonatal blood at 3 Tesla: Dependence on hematocrit, oxygenation, and temperature. Magn Reson Med (2015) 0.84
The effect of black tea and caffeine on regional cerebral blood flow measured with arterial spin labeling. J Cereb Blood Flow Metab (2013) 0.84
Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia. Brain (2016) 0.84
Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review. J Cereb Blood Flow Metab (2016) 0.84
Inter-vendor reproducibility of pseudo-continuous arterial spin labeling at 3 Tesla. PLoS One (2014) 0.83
Quantitative theory for the longitudinal relaxation time of blood water. Magn Reson Med (2015) 0.82
A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology (2015) 0.82
Oxygen-enhanced 3D radial ultrashort echo time magnetic resonance imaging in the healthy human lung. NMR Biomed (2014) 0.82
On the measurement of absolute cerebral blood volume (CBV) using vascular-space-occupancy (VASO) MRI. Magn Reson Med (2009) 0.82
Estimating cerebral blood volume with expanded vascular space occupancy slice coverage. Magn Reson Med (2009) 0.82
Cerebral perfusion differences in women currently with and recovered from anorexia nervosa. Psychiatry Res (2015) 0.81
Optimized simultaneous ASL and BOLD functional imaging of the whole brain. J Magn Reson Imaging (2013) 0.81
Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology (2013) 0.81
Implementation of vascular-space-occupancy MRI at 7T. Magn Reson Med (2012) 0.81
Fiber tract-based atlas of human white matter anatomy. Radiology (2003) 10.18
Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage (2005) 3.11
In vivo imaging of glucose uptake and metabolism in tumors. Nat Med (2013) 3.01
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med (2006) 2.87
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Spatial normalization of diffusion tensor fields. Magn Reson Med (2003) 2.70
Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med (2003) 2.68
Coordination of voluntary and stimulus-driven attentional control in human cortex. Psychol Sci (2005) 2.57
White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med (2006) 2.40
Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med (2007) 2.22
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Control of object-based attention in human cortex. Cereb Cortex (2004) 2.16
DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13
Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson (2005) 2.11
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01
Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging (2005) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study. Neuroimage (2009) 1.92
Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89
A framework for callosal fiber distribution analysis. Neuroimage (2002) 1.87
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage (2003) 1.80
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
Sustained poststimulus elevation in cerebral oxygen utilization after vascular recovery. J Cereb Blood Flow Metab (2004) 1.72
Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia--an ultrasound and MRI study. J Cereb Blood Flow Metab (2011) 1.71
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Experimental measurement of extravascular parenchymal BOLD effects and tissue oxygen extraction fractions using multi-echo VASO fMRI at 1.5 and 3.0 T. Magn Reson Med (2005) 1.56
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med (2011) 1.51
Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn Reson Imaging (2008) 1.48
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol (2002) 1.46
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed (2006) 1.42
Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke (2004) 1.41
Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc (2011) 1.41
Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging. Magn Reson Med (2005) 1.41
Territorial arterial spin labeling in the assessment of collateral circulation: comparison with digital subtraction angiography. Stroke (2008) 1.36
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magn Reson Med (2006) 1.34
Three-dimensional diffusion tensor magnetic resonance microimaging of adult mouse brain and hippocampus. Neuroimage (2002) 1.33
Measurements of cerebral perfusion and arterial hemodynamics during visual stimulation using TURBO-TILT. Magn Reson Med (2003) 1.31
Accelerated parallel imaging for functional imaging of the human brain. NMR Biomed (2006) 1.30
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry (2012) 1.29
Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology (2004) 1.27
Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology (2003) 1.26
Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain (2012) 1.25
Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol (2002) 1.24
Quantitative analysis of brain pathology based on MRI and brain atlases--applications for cerebral palsy. Neuroimage (2010) 1.24
Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid. J Magn Reson (2013) 1.23
A method for rapid in vivo measurement of blood T1. NMR Biomed (2011) 1.22
Detrimental effects of BOLD signal in arterial spin labeling fMRI at high field strength. Magn Reson Med (2006) 1.21
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21
Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J Cereb Blood Flow Metab (2013) 1.21
Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage (2012) 1.21
MRI reporter genes. J Nucl Med (2008) 1.19
Suppression of lipid artifacts in amide proton transfer imaging. Magn Reson Med (2005) 1.19
Reproducibility of primary motor cortex somatotopy under controlled conditions. AJNR Am J Neuroradiol (2002) 1.19
Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med (2004) 1.17
In vivo flow territory mapping of major brain feeding arteries. Neuroimage (2005) 1.15
In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn Reson Med (2011) 1.15
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression. J Am Chem Soc (2013) 1.15
Determination of whole-brain oxygen extraction fractions by fast measurement of blood T(2) in the jugular vein. Magn Reson Med (2010) 1.13
Evidence of slow maturation of the superior longitudinal fasciculus in early childhood by diffusion tensor imaging. Neuroimage (2007) 1.13
Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging). Magn Reson Med (2005) 1.11
Gradient-enhanced heteronuclear correlation spectroscopy: theory and experimental aspects. 1992. J Magn Reson (2011) 1.11
Cerebral border zones between distal end branches of intracranial arteries: MR imaging. Radiology (2007) 1.11
Defining an Acidosis-Based Ischemic Penumbra from pH-Weighted MRI. Transl Stroke Res (2011) 1.11